OTC: SNYNF
Market closed
--Quotes are delayed by 20 min
Sep 19, 2023, 12:23 p.m.
$
108.05
Change
-1.95 -1.77%
Volume
Volume 92
Quotes are delayed by 20 min
Previous close
$ 110.00
$ 108.05
Change
-1.95 -1.77%
Day low
Day high
$108.05
$109.32
52 week low
52 week high
$73.31
$114.90
Wolfgang Laux is on the board of Sanofi and Member-Works Council at Sanofi Chimie SA.
He received a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.
| 07/20/2023 | 250 | Acquisition at $79.58 per share. | 19,895 |
| 06/09/2023 | 9 | Acquisition at $95.12 per share. | 856 |
|
Mr. Paul Hudson Chief Executive Officer & Director |
|
Mr. Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President |
|
Mr. Emmanuel Frenehard Chief Digital Officer |
|
Dr. Dietmar P. Berger Chief Medical Officer & Global Head-Development |
|
Dr. Nestle Frank Global Head-Immunology Therapeutic Research Area |
|
Ms. Julie van Ongevalle Executive VP & Head-Consumer Healthcare |
|
Ms. Alexandra Roger Head-Securities Law & Capital Markets |
|
Mr. Brendan OCallaghan Executive Vice President & Head-Industrial Affairs |
|
Mr. Josep Catlla Head-Communication |
|
Mr. Raj Verma Chief Diversity, Culture & Experience Officer |
|
Mr. Olivier Antoine M. Charmeil Executive Vice President-General Medicines |
|
Mr. Yann Tran Director |
|
Dr. Wolfgang Laux Director |
|
Mr. Dave Stevenson Director |
|
Mr. Serge Weinberg Honorary Chairman |
|
Mr. Christophe Babule Director |
|
Ms. Eva Schäfer-Jansen Head-Investor Relations |
|
Ms. Natalie Bickford Chief People Officer & Executive Vice President |
|
Ms. Claire Terrazas Vice President-Corporate Legal Affairs |
|
Mr. Roy Papatheodorou EVP, General Counsel & Head-Legal |
|
Mr. Arnaud Delépine Investor Relations Contact |
|
Mr. Frédéric Oudéa Chairman |
|
Ms. Rachel Duan Independent Non-Executive Director |
|
Ms. Lise Kingo Independent Director |
|
Mr. Gilles Schnepp Independent Director |
|
Ms. Barbara Lavernos Independent Director |
|
Ms. Carole Gabriella Ferrand Independent Director |
|
Dr. Emile Voest Independent Director |
|
Dr. Antoine Yver Independent Director |
|
Ms. Fabienne Lecorvaisier Independent Director |
|
Mr. Patrick Kron Independent Director |
|
Ms. Diane D. Souza Independent Director |
|
Dr. Thomas C. Südhof Independent Director |
Yields Are Near Their Peak. You Shouldn't Wait to Buy Bonds.
Hollywood writers, studio execs meet for second straight day, but no deal yet
Former Bridgewater CEO David McCormick launches second Senate bid in Pennsylvania
U.K. consumer confidence improves to highest level since January 2022
By buying Splunk, Cisco is closer to becoming a software company
Nippon Television acquires iconic animation company Studio Ghibli
Tropical storm warning issued for East Coast ahead of potential cyclone
Japan’s overall consumer prices continued to rise more than 3% in August
Wildfire-prone California to consider new rules for property insurance pricing
Risk of government shutdown soars as House Republicans leave town in disarray amid hard-right revolt
On Capitol Hill, Zelensky delivers upbeat message on war’s progress as Republican support softens
Faraday Future’s top execs agree to salary deduction, stock-purchase agreement plan
Adidas CEO has apologized for remarks about Kanye West, ADL head says
Here’s why Cisco may want to close the Splunk deal sooner rather than later
DuckDuckGo founder says Google’s partnerships thwart competition
Alerts
Virtual Stock Exchange
Copyright © 2023 MarketWatch, Inc. All rights reserved.
Subscriber Agreement & Terms of Use |
Privacy Notice |
Cookie Notice
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.